Description

2-(3-Acetylamino-2,4,6-Triiodophenyl)Valeric Acid is a specialized iodinated organic compound primarily used as a key intermediate in the synthesis of X-ray contrast media. Its value lies in its precise molecular structure, which is engineered for high radiopacity and targeted pharmacokinetics in diagnostic imaging agents. This product is essential for pharmaceutical manufacturers and advanced research facilities developing next-generation non-ionic, low-osmolar contrast agents for computed tomography (CT) and angiography.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of iopamidol, ioversol, and other non-ionic iodinated contrast media.
• Diagnostic Imaging Agent Precursor: Used in research and production of advanced X-ray and CT scan contrast agents for enhanced vascular and organ visualization.
• Medical Research: Serves as a key starting material in academic and industrial R&D for novel radiopaque compounds and targeted imaging probes.
• Contrast Media Formulation: Integral to the development of safer, low-osmolar formulations that reduce patient side effects during diagnostic procedures.
• Chemical Synthesis: Employed in organic synthesis for introducing the triiodophenyl moiety into complex molecules for various research applications.

Basic Information

Product Name	2-(3-Acetylamino-2,4,6-Triiodophenyl)Valeric Acid
CAS No.	23217-87-0
Molecular Formula	C13H15I3N2O3
Molecular Weight	635.98 g/mol
Synonyms	5-[3-(Acetylamino)-2,4,6-triiodophenyl]pentanoic Acid; 2-(3-Acetamido-2,4,6-triiodophenyl)valeric Acid; Iopamidol Intermediate; Ioversol Intermediate; N-Acetyl-3-amino-2,4,6-triiodohydrocinnamic Acid Derivative; 3-Acetamido-2,4,6-triiodophenylvaleric Acid; 23217-87-0; 5-(3-Acetamido-2,4,6-triiodophenyl)valeric Acid
EINECS	Contact for details

Quality Control

Every batch of 2-(3-Acetylamino-2,4,6-Triiodophenyl)Valeric Acid is manufactured and tested under a strict quality management system. We provide comprehensive analytical data to ensure the material meets the high-purity standards required for pharmaceutical synthesis. A detailed Certificate of Analysis (COA) is supplied with each shipment, confirming identity, purity, and impurity profiles as per client specifications or standard pharmacopeial guidelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to prevent moisture absorption, which can affect stability and purity. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Individual Unknown Impurity	≤ 0.5%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.